Doctor profile · Federal record

Dr. Katie Agnello, M.D.

Gastroenterology Physician (CMS: Gastroenterology) · Venice, FL

  • NPI 1841432705
  • Accepts Medicare
  • MIPS 96.6 / 100 · 2023
  • 17 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
825 Venetian Pkwy
Venice, FL 342857163
(941) 483-5730

Credentials & registration

NPPES · NUCC
NPI registered
March 2009 — 17 yrs on file
Profile last updated
April 19, 2018
Year of graduation
2009 — 17 yrs since
Specialty taxonomy
207RG0100X — NUCC code
State license (1)
Florida #ME121751

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1841432705. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
14,430
Distinct HCPCS
10
Medicare allowed
$453,197
HCPCS Description Services Patients Avg allowed
J3380 Injection, vedolizumab, 1 mg 11,100 21 $22
J1745 Injection, infliximab, excludes biosimilar, 10 mg 2,001 13 $33
99213 Established patient office or other outpatient visit, 20-29 minutes 501 426 $89
45380 Biopsy of large bowel using a flexible endoscope 203 203 $88
45385 Removal of polyps or growths of large bowel using an endoscope with mechanical snare 157 157 $248
43239 Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope 125 124 $83
99203 New patient office or other outpatient visit, 30-44 minutes 91 91 $112
99202 New patient office or other outpatient visit, 15-29 minutes 58 58 $71
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 41 24 $62
43248 Insertion of guide wire with dilation of esophagus using a flexible endoscope 34 33 $143

In context: peer comparison

Among 2 peers in Venice Gastroenterology Physician, average services per provider: 969. This provider delivers 15× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,267
Transactions
93
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Abbvie INC. 30 $604.36
Takeda Pharmaceuticals U.S.A., INC. 10 $216.53
Janssen Biotech, INC. 8 $181.66
Celgene Corporation 6 $170.56
Pfizer INC. 8 $140.02
Salix Pharmaceuticals, A Division of Bausch Health US, LLC 5 $105.24
Ironwood Pharmaceuticals, INC 4 $97.20
Ardelyx, INC. 4 $82.23
Fujifilm Healthcare Americas Corporation 1 $71.39
Regeneron Healthcare Solutions, INC. 3 $67.44
Lilly USA, LLC 3 $60.91
Intercept Pharmaceuticals, INC. 3 $60.87
Aimmune Therapeutics, INC. 4 $57.86
Genzyme Corporation 2 $52.42
Ipsen Biopharmaceuticals, INC 2 $47.32

By nature of payment

Food and Beverage
$2,251
Education
$16

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,232
Patients
545
Total drug cost
$1,299,125
Drug Type Claims Patients Total cost
Omeprazole Generic 441 164 $6,712
Pantoprazole Sodium Generic 182 65 $3,623
Famotidine Generic 77 35 $1,489
Linzess (Linaclotide) Brand 75 29 $81,326
Sutab (Sod Sulf/Pot Chloride/Mag Sulf) Brand 72 71 $12,148
Dicyclomine Hcl Generic 52 24 $1,889
Clenpiq (Sod Picosulf/Mag Ox/Citric Ac) Brand 45 44 $7,962
Creon (Lipase/Protease/Amylase) Brand 44 21 $225,503
Sucralfate Generic 42 21 $3,212
Budesonide Dr (Budesonide) Brand 39 16 $5,787

Frequently asked questions

Auto-generated from federal data
What is Dr. Katie Agnello's medical specialty?
Dr. Katie Agnello practices Gastroenterology Physician in Venice, FL.
Where does Dr. Katie Agnello practice?
Dr. Katie Agnello practices at 825 Venetian Pkwy, Venice, FL 342857163. Office phone: 9414835730.
What is Dr. Katie Agnello's NPI?
Dr. Katie Agnello's National Provider Identifier (NPI) is 1841432705, issued by NPPES.
Does Dr. Katie Agnello accept Medicare assignment?
Yes. Dr. Katie Agnello accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Katie Agnello commonly perform?
Top Medicare-reported procedures in 2023: Injection, vedolizumab, 1 mg (HCPCS J3380); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.